3rd Symposium on Rare Cardiovascular Diseases – ESC Amsterdam 2013: Chairperson’s Perspective
Journal Title: Journal of Rare Cardiovascular Diseases - Year 2013, Vol 1, Issue 4
Abstract
The 3rd Satellite Symposiumon Rare Cardiovascular Diseases, which was organized by the Krakow Center for Rare Cardiovascular Diseases, was officially included in the Program of the 2013 ESC Congress and was held in the ESC Congress Venue on 2nd September 2013. The session was chaired by the world-class heart failure specialist Professor John Cleland from Kingston-upon-Hull, UK and Doctor Pawel Rubis from Krakow, Poland. In brief, the session program followed the previously established layout of two introductory and final mini-lectures, the keynote lecture and two case-based presentations.The session was opened by the Director of the Krakow Center for Rare Cardiovascular Diseases, Professor Piotr Podolec, who delivered lecture on newly developed, by the joint effort of many Experts and Partners, the Classification of Rare Cardiovascular Diseases. The Keynote Lecture, entitled “New Frontiers in cardiac surgery treatment of patients with rare cardiovascular diseases” was delivered by the Professor Ottavio Alfieri from Milan, Italy. The first case on the management of pregnant patient with heart failure on the basis of end stage hypertrophic cardiomyopathy with secondary pulmonary hypertension, was presented by Doctor Lidia Tomkiewicz-Pająk and commented by Professor Sabine Pankuweit from Marburg, Germany and Professor Deddo Moertl from St. Poelten, Austria. The second case on the management of middle-age woman with unoperated tetralogy of Fallot and concomitant aortic stenosis was delivered by Associate to Professor Andrzej Gackowski, and discussed by Professor Egle Erminiene from Kaunas, Lithuania and Doctor Jakub Podolec from Krakow Center. The final presentation was given by Doctor Grzegorz Kopeć from our Center who focused on the registries of rare cardiovascular diseases. This year, the great debate concentrated on the newly-proposed Classification of Rare Cardiovascular Diseases.
Authors and Affiliations
Paweł Rubiś
Keywords
Related Articles
- EP ID EP248139
- DOI 10.20418/jrcd.vol1no4.120
- Views 112
- Downloads 0
Combination therapy in the treatment of pulmonary arterial hypertension - 2015 update.
Pulmonary arterial hypertension (PAH) is a disease with a poor prognosis and high mortality rates therefore in the era of advanced therapies targeting different patophysiological pathways attractive seems the idea of com...
Pulmonary arterial hypertension: management in specific medical conditions
Pulmonary arterial hypertension (PAH) is a severe and progressive disease. Due to the narrowing of the blood vessels in the lungs, pul- monary vascular resistance and pulmonary pressures increase. This results in reduced...
For one mistake made for not knowing, ten mista kes are made for not looking
And yet again, summer solstice is just behind the cor‑ ner. As the time passes so quickly, do we really have a chance to use it profitability? One way is to study hard and be up‑to‑date. Then we know new and com‑ plex sy...
Partial anomalous pulmonary venous connection (RCD code: II-3C.0)
A 48-year-old woman was admitted to our institution with a year’s history of uncharacteristic chest pain episodes and decrease in exercise tolerance. A CT lung scan performed nine months earlier revealed an anomalous vei...
Ebstein Anomaly
Ebstein anomaly (EA) is a rare congenital malformation of the heart that is characterized by apical displacement of the septal and posterior tricuspid valve leaflets, with atrialization of the right ventricle and variabl...